| Molecular biomarkers in multiple sclerosis T Ziemssen, K Akgün, W Brück Journal of neuroinflammation 16 (1), 272, 2019 | 214 | 2019 |
| The role of TH17 cells in multiple sclerosis: Therapeutic implications T Moser, K Akgün, U Proschmann, J Sellner, T Ziemssen Autoimmunity reviews 19 (10), 102647, 2020 | 175 | 2020 |
| Digital twins for multiple sclerosis I Voigt, H Inojosa, A Dillenseger, R Haase, K Akgün, T Ziemssen Frontiers in immunology 12, 669811, 2021 | 137 | 2021 |
| A focus on secondary progressive multiple sclerosis (SPMS): challenges in diagnosis and definition H Inojosa, U Proschmann, K Akgün, T Ziemssen Journal of neurology 268, 1210-1221, 2021 | 133 | 2021 |
| Profiling individual clinical responses by high-frequency serum neurofilament assessment in MS K Akgün, N Kretschmann, R Haase, U Proschmann, HH Kitzler, ... Neurology: Neuroimmunology & Neuroinflammation 6 (3), e555, 2019 | 106 | 2019 |
| Alemtuzumab in the long-term treatment of relapsing-remitting multiple sclerosis: an update on the clinical trial evidence and data from the real world T Ziemssen, K Thomas Therapeutic advances in neurological disorders 10 (10), 343-359, 2017 | 106 | 2017 |
| Use and acceptance of electronic communication by patients with multiple sclerosis: a multicenter questionnaire study R Haase, T Schultheiss, R Kempcke, K Thomas, T Ziemssen Journal of medical Internet research 14 (5), e2133, 2012 | 104 | 2012 |
| Multiple sclerosis: clinical profiling and data collection as prerequisite for personalized medicine approach T Ziemssen, R Kern, K Thomas BMC neurology 16 (1), 124, 2016 | 91 | 2016 |
| Peripheral proinflammatory Th1/Th17 immune cell shift is linked to disease severity in amyotrophic lateral sclerosis M Jin, R Günther, K Akgün, A Hermann, T Ziemssen Scientific reports 10 (1), 5941, 2020 | 84 | 2020 |
| Acute effects of alemtuzumab infusion in patients with active relapsing-remitting MS K Thomas, J Eisele, FA Rodriguez-Leal, U Hainke, T Ziemssen Neuroimmunology & Neuroinflammation 3 (3), e228, 2016 | 80 | 2016 |
| Engrafting human regulatory T cells with a flexible modular chimeric antigen receptor technology S Koristka, A Kegler, R Bergmann, C Arndt, A Feldmann, S Albert, ... Journal of Autoimmunity 90, 116-131, 2018 | 69 | 2018 |
| Fingolimod additionally acts as immunomodulator focused on the innate immune system beyond its prominent effects on lymphocyte recirculation K Thomas, T Sehr, U Proschmann, FA Rodriguez-Leal, R Haase, ... Journal of Neuroinflammation 14, 1-13, 2017 | 64 | 2017 |
| Natalizumab during pregnancy and lactation U Proschmann, K Thomas, S Thiel, K Hellwig, T Ziemssen Multiple Sclerosis Journal 24 (12), 1627-1634, 2018 | 61 | 2018 |
| Cortisol awakening response is linked to disease course and progression in multiple sclerosis S Kern, I Krause, A Horntrich, K Thomas, J Aderhold, T Ziemssen PLoS One 8 (4), e60647, 2013 | 55 | 2013 |
| Digital biomarkers in multiple sclerosis A Dillenseger, ML Weidemann, K Trentzsch, H Inojosa, R Haase, ... Brain sciences 11 (11), 1519, 2021 | 54 | 2021 |
| Fingolimod hydrochloride for the treatment of relapsing remitting multiple sclerosis K Thomas, U Proschmann, T Ziemssen Expert opinion on pharmacotherapy 18 (15), 1649-1660, 2017 | 51 | 2017 |
| Designing an electronic patient management system for multiple sclerosis: building a next generation multiple sclerosis documentation system R Kern, R Haase, JC Eisele, K Thomas, T Ziemssen Interactive Journal of Medical Research 5 (1), e4549, 2016 | 51 | 2016 |
| Long‐term peripheral immune cell profiling reveals further targets of oral cladribine in MS T Moser, K Schwenker, M Seiberl, J Feige, K Akgün, E Haschke‐Becher, ... Annals of Clinical and Translational Neurology 7 (11), 2199-2212, 2020 | 50 | 2020 |
| New insights into the pharmacokinetics and pharmacodynamics of natalizumab treatment for patients with multiple sclerosis, obtained from clinical and in vitro studies T Sehr, U Proschmann, K Thomas, M Marggraf, E Straube, H Reichmann, ... Journal of neuroinflammation 13, 1-11, 2016 | 49 | 2016 |
| Multiple sclerosis documentation system (MSDS): moving from documentation to management of MS patients T Ziemssen, R Kempcke, M Eulitz, L Großmann, A Suhrbier, K Thomas, ... Journal of Neural transmission 120, 61-66, 2013 | 48 | 2013 |
